'Breakthrough' could lead to therapies for rare blood clots linked to AstraZeneca COVID-19 vaccine

Doctors from Germany and Austria say they've not only figured out the mechanism behind a rare form of thrombosis linked to the AstraZeneca vaccine, but have also developed a diagnostic tool and a suggested therapy to "clear it up immediately."